Raltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity Raltegravir

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 180/kg
Request Sample
Diamond Member Since 2024

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

In-stock Capacity
The supplier has In-stock capacity
Fast Delivery
The supplier can deliver the goods within 15 days
OEM Services
The supplier provides OEM services for popular brands
R&D Capabilities
The supplier has 1 R&D engineers, you can check the Audit Report for more information
to see all verified strength labels (13)
  • Raltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity Raltegravir
  • Raltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity Raltegravir
  • Raltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity Raltegravir
  • Raltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity Raltegravir
  • Raltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity Raltegravir
  • Raltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity Raltegravir
Find Similar Products

Basic Info.

Certification
GMP, ISO 9001, USP
Suitable for
Adult
Purity
>99%
Sample
Available
OEM
Available
MOQ
1kg
CAS
518048-05-0
Keyword
Raltegravir
Keyword 1
Raltegravir Powder
Transport Package
1kg Foil Bag /25kg Drum
Specification
99%
Trademark
/
Origin
China
Production Capacity
20000

Product Description

Raltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity Raltegravir
Description

Raltegravir, also known as MK-0518, is an antiretroviral drug used to treat HIV infection. Raltegravir is a human immunodeficiency virus (HIV) integrase strand transfer inhibitor (HIV-1 INSTI) with HIV-1

Product name Raltegravir
Appearance white Powder
Specification 99%
Shelf life 2 years when properly stored

Function and Application

Raltegravir binds to and inhibits integrase, an HIV enzyme that inserts viral genetic material into the genetic material of the infected human cell. Inhibition of integrase prevents insertion of HIV DNA into the human DNA genome, thus blocking HIV replication. It received approval by the U.S.
It can be combined with other antiretroviral drugs for the treatment of human immunodeficiency virus (HIV) -1 infection. It slows down HIV-1 infection by inhibiting the HIV integrase required for viral replication.

Raltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity RaltegravirRaltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity RaltegravirRaltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity RaltegravirRaltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity RaltegravirRaltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity RaltegravirRaltegravir Powder CAS 518048-05-0 Anti-Aids Raltegravir Purity Raltegravir

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier